Evolent Health Inc Class A (EVH)

R&D Expenses

$0.00

Quarterly · Period ending: · USD

EVH logo

EVH R&D Expenses

Latest reported$0.00
EVH Quarterly R&D Expenses ($2.00M → $0.00)
High-resolution chart · PNG

EVH r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evolent Health Inc Class A R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
0
0
0
0
0
0
0
0
0
0
6,600,000
6,600,000
0
0
0
0
0
0
6,500,000
0
0
0
0
0
0
0
0
4,900,000
4,500,000
4,100,000
30,600,000
0
2,900,000
2,500,000
19,300,000
1,200,000
900,000
700,000
11,600,000
400,000
300,000
200,000
5,800,000
0
0
0
0
0
0
0
2,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.